Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial

Post time 1 hour(s) ago

journal：Blood

Authors：Moritz Fürstenau; Carsten U. Niemann; Sandra Robrecht; Emelie C. Rotbain; Laura Eurelings; Adam Giza; Julia von Tresckow; Can Zhang; Michael Gregor; Patrick Thornton; Philipp B. Staber; Tamar Tadmor; Vesa Lindstrm; Gunnar Juliusson; Ann Janssens; Caspar da Cunha-Bang; Christof Schneider; Yair Herishanu; Derville O’Shea; Michael Baumann; Anouk Widmer; Thomas Nsslinger; Christian B. Poulsen; Henrik Frederiksen; Kourosh Lotfi; Juha Ranti; Lisbeth Enggaard; Gerjo Velders; Marie-Christiane Vekemans; Koen de Heer; Tjeerd F. Snijders; Claire Siemes; Clemens-Martin Wendtner; Wolfgang Knauf; Alexander Kroeber; Mark-Oliver Zahn; Thomas Illmer; Bjrn Schttker; Florian Simon; Anna Fink; Kirsten Fischer; Ronald D’Brot; Emily Holmes; Karl-Anton Kreuzer; Matthias Ritgen; Monika Brüggemann; Eugen Tausch; Stephan Stilgenbauer; Mark-David Levin; Michael Hallek; Arnon P. Kater; Barbara Eichhorst

Published date：2026-6-18

DOI：10.1182/blood.2025032160

PDF link：https://ashpublications.org/bloo ... 025-032160-main.pdf

Article link：https://doi.org/10.1182/blood.2025032160

Article Source：American Society of Hematology。

Remark：

[Other] Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial